This podcast provides an overview of current and emerging data available in the treatment of EGFR Exon 20 Insertion Mutation Non-Small Cell Lung Cancer, including updates from ESMO 2023. Key takeaways:- Review treatment options for EGFR Exon 20 Insertion Mutations in NSCLC - Review updated clinical data from ELCC and ESMO 2023 - Gain an understandi…

This is the third episode in our series on myelodysplastic syndromes (MDS) which aims to update clinicians on the latest developments in their diagnosis and management. In this episode, Dr. DiNardo discusses the missing pieces of MDS management, starting with the latest approvals in MDS treatment and how eligibility for clinical trials is assessed.…

This is the second episode in our series on myelodysplastic syndromes (MDS) which aims to update clinicians on the latest developments in their diagnosis and management. In this episode, Dr. Griffiths discusses what makes Real World Evidence and how it is obtained or archived, the risk stratification of MDS and what that means for gathering evidenc…

This is the first episode in our series on myelodysplastic syndromes which aims to update clinicians on the latest developments in their diagnosis and management. In this episode, Dr. DeFilipp outlines the current and upcoming treatments for myelodysplastic syndromes. He discusses doublet and triplet combinations that are moving the needle on disea…

This is the third episode in our series on cholangiocarcinoma which aims to update clinicians on the latest developments in its diagnosis and management. In this episode, Melinda Bachini discusses the use of biomarker testing in cholangiocarcinoma. From the perspective of a patient advocate, she explains how to relay complex information about bioma…

This is the second episode in our series on cholangiocarcinoma which aims to update clinicians on the latest developments in its diagnosis and management. In this episode, Dr. Marina Baretti discusses the safety of fibroblast growth factor receptor (FGFR) inhibitors, drawing from her clinical experience. She details current safety data, and explain…

This is the first episode in our series on cholangiocarcinoma which aims to update clinicians on the latest developments in its diagnosis and management. In this episode, Dr. Sameek Roychowdhury discusses fibroblast growth factor receptor (FGFR) inhibitors in the management of cholangiocarcinoma—how long they’ve been in use, and what we know about …

This is the third episode in our series on colorectal cancer which aims to update clinicians on the latest developments in the management of colorectal cancer. In this episode, Dr. Ben George discusses the importance of real-world data in managing metastatic colorectal cancer care outcomes, and the inescapable truths of daily life that impact patie…

This is the second episode in our series on colorectal cancer which aims to update clinicians on the latest developments in the management of colorectal cancer. In this episode, Dr. Reetu Mukherji discusses unmet needs in the treatment landscape of colorectal cancer. She explains where the greatest needs are in current management, and what research…

This is the first episode in our series on colorectal cancer which aims to update clinicians on the latest developments in treatment. In this episode, Dr. Arvind Dasari starts by explaining the current management of colorectal cancer, and then outlines the latest developments in immunotherapy and targeted therapies, touching on specific trials pres…

Welcome to the third episode in a three-part special live from ESMO 2022. In this episode focused on breast cancer we speak with Dr Hope Rugo, Director of Breast Oncology and Clinical Trials Education at the University of California San Francisco (UCSF) Helen Diller Family Comprehensive Cancer Center. Dr Rugo summarizes the TROPICS02 trial that she…

Welcome to the second episode in a three-part special live from ESMO 2022. In this episode focused on breast cancer, we speak with Dr Shaheenah Dawood, a practicing medical oncologist from Dubai, United Arab Emirates. Dr Dawood discusses the MONARCH3 trial – its background, recent findings and how it differs from the MONARCHER trial. Coverage is al…

Welcome to the first episode in a three-part special live from ESMO 2022. In this episode focused on colorectal cancer, we speak with Dr Chetan Deshmukh, a practicing medical oncologist from Pune, India. Dr Deshmukh discusses the results from the CARIO5 study, which have been presented at the congress. He also shares with us his thoughts on the pro…

The fifth and final episode of our special series on breast cancer for Karger’s Fast Facts Oncology Podcast. In episode we are joined by Abeda Steenkamp, breast cancer survivor and Service Coordinator for the Cancer Association of South Africa. Join us as we talk about stigma and taboos surrounding breast cancer in South Africa (CANSA). Furthermore…

The fourth episode in a five-part special on breast cancer for Karger’s Fast Facts Oncology Podcast. In this episode we are joined by Dr Omar Hamid from Nairobi Kenya. Dr Omar is a clinical oncologist and passionate advocate for affordable cancer care. Listen in as we discuss whether advances in breast cancer treatment are really a boon for patient…

The third episode in a five-part special on breast cancer for Karger’s Fast Facts Oncology Podcast. In this episode we are again joined by Dr Shaheenah Dawood, a consultant medical oncologist and professor in clinical oncology from the United Arab Emirates, for the second part of our discussion on the ‘changing landscape in managing breast cancer p…

The second episode in a five-part special on breast cancer for Karger’s Fast Facts Oncology Podcast. In this episode we are joined by Dr Shaheenah Dawood, a consultant medical oncologist and professor in clinical oncology from the United Arab Emirates, to discuss the changing landscape in managing breast cancer patients. To accompany this series on…

The first episode in a five-part special on breast cancer for Karger’s Fast Facts Oncology Podcast. In this episode we are joined by Dr Vinicius Knackfuss Gonçalves from the Hospital São Lucas da PUCRS, in Porto Alegre Brazil to discuss the topic of penetration of breast cancer screening in low middle income countries. To accompany this series on b…

Presenter: Philip R. Muskin MD, MA, DLFAPA Professor of Psychiatry Columbia University Irving Medical Center Senior Consultant in Consultation-Liaison Psychiatry New York-Presbyterian Hospital New York, NY Chronic medical illnesses such as cancer are characterized by a notably increased prevalence of depression. Furthermore, several challenges may …

Presenter: Hope S. Rugo MD Professor of Medicine University of California San Francisco Comprehensive Cancer Center TNBC comprises approximately 15% of newly diagnosed breast cancer cases and is defined by being estrogen-receptor negative, progesterone-receptor negative, and human epidermal growth factor receptor 2-negative. This breast cancer subt…

Presenter: Gail J. Roboz MD Professor of Medicine Director, Clinical and Translational Leukemia Program Weill Medical College of Cornell University New York-Presbyterian Hospital New York, New York, United States This brief program will begin with a review of NCCN Guidelines® Recommendations for the treatment of AML in individuals 60 years of age o…